Literature DB >> 1319459

Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.

J D MacMicking1, D O Willenborg, M J Weidemann, K A Rockett, W B Cowden.   

Abstract

Perivascular lesions within the central nervous system (CNS) of rats with hyperacute experimental autoimmune encephalomyelitis (HEAE) contained large numbers of peripheral blood mononuclear cells (PBMC) and polymorphonuclear leukocytes (PMN), cells enzymatically capable of producing reactive nitrogen and oxygen intermediates (RNI and ROI), which, in excess, are mediators of tissue damage. PBMC and PMN isolated from the CNS and periphery of HEAE-affected rats secreted significantly (p less than 0.01-0.0001) elevated levels of ROI and RNI compared with that of similar cell populations from pertussis- and saline-treated control animals. Coincubation of systemically derived PBMC and PMN with antigen-stimulated myelin basic protein-specific T cell lines led to further increases in ROI and RNI output of between 15.3 and 83.1%, an effect that could be largely attributed to heat-labile, soluble products released by these T cell lines. Our studies suggest a putative neuropathological role for ROI and RNI in HEAE, which may be mediated via cytokines emanating from autoreactive T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319459      PMCID: PMC2119289          DOI: 10.1084/jem.176.1.303

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils.

Authors:  R A Clark; S J Klebanoff
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

2.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

Authors:  V L Dawson; T M Dawson; E D London; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.

Authors:  A H Cross; B Cannella; C F Brosnan; C S Raine
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

5.  Contribution of nitric oxide synthase to luminol-dependent chemiluminescence generated by phorbol-ester-activated Kupffer cells.

Authors:  J F Wang; P Komarov; H Sies; H de Groot
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

7.  Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum.

Authors:  I A Clark; J D MacMicking; K M Gray; K A Rockett; W B Cowden
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.

Authors:  N H Ruddle; C M Bergman; K M McGrath; E G Lingenheld; M L Grunnet; S J Padula; R B Clark
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.

Authors:  I Huitinga; N van Rooijen; C J de Groot; B M Uitdehaag; C D Dijkstra
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 2.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

Review 3.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

4.  Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

Authors:  Mariana Vaini de Freitas; Marcela Ramos de Oliveira; Diogo Fernandes dos Santos; Rita de Cássia Mascarenhas Netto; Sheila Bernardino Fenelon; Nilson Penha-Silva
Journal:  J Membr Biol       Date:  2010-02-10       Impact factor: 1.843

5.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

Review 6.  Inducible nitric oxide synthase in inflammation.

Authors:  V Cattell; A Jansen
Journal:  Histochem J       Date:  1995-10

7.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

Authors:  H Sakurai; H Kohsaka; M F Liu; H Higashiyama; Y Hirata; K Kanno; I Saito; N Miyasaka
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.